increments of 1000 mg, to a maximum recommended daily dose of 3000 mg. KEPPRA: 3000 mg/day. Placebo. Oral. Part I: Efficacy under add-on
every 2 weeks to a maximum recommended dose of 3000 mg once daily (2). See In these studies, 904 patients were randomized to placebo, KEPPRA 1000 mg, KEPPRA.
Additional dosing increments may be given (1000 mg/day additional every 2 weeks) to a maximum recommended daily dose of 3000 mg. Doses greater than 3000 mg/day have been used in open label studies with KEPPRA tablets for periods of 6 months and longer. There is no evidence that doses greater than 3000 mg/day confer additional benefit.
The recommended dose range of Keppra for the treatment of partial onset seizures in adults is 1000 to 3000 mg, equally divided into 2 doses per
See Table 1 for the recommended preparation and administration of Keppra concentrate to achieve a total daily dose of 500 mg, 1000 mg, 2024 mg, or 3000 mg in two divided doses. Table 1. Preparation and administration of Keppra concentrate
The maximum daily dose was 3000 mg/day. 2.2. Dosing for Myoclonic Seizures in When using KEPPRA injection for pediatric patients, dosing is weight-based (mg
Need for oral loading dose not established Immediate-release (Keppra, Spritam): 500 mg PO q12hr; may increase q2week by 500 mg/dose; not to exceed 3000 mg/day Extended-release (Keppra XR or Elepsia XR): 1000 mg PO qDay; may increase q2week by 1000 mg/day; not to exceed 3000 mg/day
Additional dosing increments may be given (1000 mg/day additional every 2 weeks) to a maximum recommended daily dose of 3000 mg. Doses greater than 3000 mg/day have been used in open label studies with KEPPRA tablets for periods of 6 months and longer. There is no evidence that doses greater than 3000 mg/day confer additional benefit.
dose of 3000 mg (1500 mg twice daily). KEPPRA Oral Solution Weight-Based Dosing Calculation For Pediatric Patients. The following calculation should be used
Comments